Reply to "Are there reasons to prefer tetracyclines to macrolides in older patients with community-acquired pneumonia?"

Antimicrob Agents Chemother. 2013 Aug;57(8):4094. doi: 10.1128/AAC.00864-13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Clostridioides difficile / drug effects*
  • Community-Acquired Infections / etiology*
  • Enterocolitis, Pseudomembranous / etiology*
  • Humans

Substances

  • Anti-Bacterial Agents